International Flavors&Fragranc Stock Price, News & Analysis

IFF has appointed Dirk Lauven as Master Perfumer, recognizing his 30-year career in the global perfumery industry. Lauven, who joined IFF in 2017 and has a track record of commercial excellence, is the company’s eighth Master Perfumer. Andreas Fibig, IFF’s CEO, praised Lauven's creativity and ability to drive innovation into commercial results. Lauven expressed excitement about mentoring the next generation of perfumers. His tenure at IFF has been marked by significant growth following the acquisition of Fragrance Resources, where he previously served as CEO Europe.

IFF (NYSE: IFF) announced that CEO Andreas Fibig will speak at the Consumer Analyst Group of New York's annual conference, set for February 17, 2021, at 10:40 a.m. ET. This session will be available as a pre-recorded webcast, with a replay accessible afterward at ir.iff.com. IFF specializes in food, beverage, health, biosciences, and sensorial experiences, creating innovative solutions that enhance global consumer products.

International Flavors & Fragrances reported a mixed performance for Q4 and the full year 2020. Q4 sales totaled $1.3 billion, a slight decline from 2019. Operating profit decreased to $101 million and EPS was $0.57, down from $0.70. For FY 2020, sales stood at $5.1 billion, reflecting a 1% decline, with EPS at $3.21, compared to $4.00 in 2019. Despite challenges, leadership expressed optimism for 2021, predicting stronger results driven by an enhanced platform and reduced net debt. Pro-forma sales for 2021 are projected at approximately $11.5 billion.

DuPont announced the final results of its exchange offer related to the merger with International Flavors & Fragrances Inc. (IFF). A total of 368,655,051 shares were tendered, with a proration factor of 52.53%. Holders of 197,410,113 shares, approximately 27% of DuPont's outstanding shares, exchanged their stock for N&B common stock at an exchange ratio of 0.7180, resulting in receiving IFF shares post-merger. The transaction was supported by Goldman Sachs, J.P. Morgan, and Evercore as financial advisors.

IFF (NYSE: IFF) has unveiled a new brand identity following its merger with DuPont's Nutrition & Biosciences division, aimed at enhancing its role in the consumer goods and commercial products value chain. The new tagline, Where science and creativity meet, reflects IFF's commitment to innovation and customer-centric solutions. Key elements include a core vision of being an essential solutions partner and three commitments: Question Everything, Champion Creators, and Do More Good. The company seeks to drive sustainability and foster a strong execution culture.

IFF has successfully completed the merger with DuPont's Nutrition & Biosciences (N&B) business through a Reverse Morris Trust transaction. The new company will operate under the IFF name, with pro forma revenue exceeding $11 billion and EBITDA at approximately $2.5 billion. DuPont shareholders will own 55.4% of the combined entity, while IFF shareholders will hold 44.6%. This merger aims to create a global leader in high-value ingredients across various markets, enhancing IFF's capabilities to deliver innovative solutions tailored to increasing consumer demand for healthier products.

DuPont has announced a final exchange ratio of 0.7180 shares of Nutrition & Biosciences, Inc. (N&B) for each share of DuPont common stock tendered in its exchange offer. This offer relates to DuPont's Reverse Morris Trust transaction with International Flavors & Fragrances Inc. (IFF). If fully subscribed, DuPont expects to exchange approximately 197.4 million shares. The exchange offer expires at 11:59 PM on January 29, 2021. N&B will merge with IFF, converting each N&B share into one share of IFF stock, affecting DuPont shareholders who tender their shares.

In its latest announcement, IFF (NYSE:IFF) revealed preliminary financial results for the fourth quarter and full year ended December 31, 2020. Expected net sales for Q4 2020 are around $1,270 million, slightly down from $1,284 million in Q4 2019, while full-year sales are projected at $5,084 million. Operating profit for Q4 is anticipated to be $100 million, with an adjusted operating profit of approximately $203 million. IFF attributes its performance to its diverse portfolio and resilience during the pandemic. The company is set to complete its merger with DuPont Nutrition & Biosciences shortly, with strong value creation anticipated.

On December 31, 2020, DuPont commenced an exchange offer for stockholders to tender shares for Nutrition & Biosciences (N&B) stock. This action is part of a Reverse Morris Trust transaction with International Flavors & Fragrances (IFF). For Q4 2020, DuPont expects GAAP EPS between $0.35 and $0.37 on net sales of approximately $5.25 billion. Full year 2020 anticipates a GAAP loss per share of $(3.97) to $(3.95) on approximately $20.40 billion in sales. The final financial results will be announced on February 9, 2021.